Literature DB >> 18946304

Addiction and substance abuse in anesthesiology.

Ethan O Bryson1, Jeffrey H Silverstein.   

Abstract

Despite substantial advances in our understanding of addiction and the technology and therapeutic approaches used to fight this disease, addiction still remains a major issue in the anesthesia workplace, and outcomes have not appreciably changed. Although alcoholism and other forms of impairment, such as addiction to other substances and mental illness, impact anesthesiologists at rates similar to those in other professions, as recently as 2005, the drug of choice for anesthesiologists entering treatment was still an opioid. There exists a considerable association between chemical dependence and other psychopathology, and successful treatment for addiction is less likely when comorbid psychopathology is not treated. Individuals under evaluation or treatment for substance abuse should have an evaluation with subsequent management of comorbid psychiatric conditions. Participation in self-help groups is still considered a vital component in the therapy of the impaired physician, along with regular monitoring if the anesthesiologist wishes to attempt reentry into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946304      PMCID: PMC2766183          DOI: 10.1097/ALN.0b013e3181895bc1

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  76 in total

1.  Combined Alcoholics Anonymous and professional care for addicted physicians.

Authors:  M Galanter; D Talbott; K Gallegos; E Rubenstone
Journal:  Am J Psychiatry       Date:  1990-01       Impact factor: 18.112

2.  Physicians in recovery.

Authors:  R K White; E J Kitlowski
Journal:  Md Med J       Date:  1988-03

3.  Whither the impaired physician? The politics of impairment.

Authors:  E T Carden
Journal:  Md Med J       Date:  1988-03

4.  Assessment of laboratory quality in urine drug testing. A proficiency testing pilot study.

Authors:  K H Davis; R L Hawks; R V Blanke
Journal:  JAMA       Date:  1988 Sep 23-30       Impact factor: 56.272

5.  Families and physician impairment.

Authors:  J S Samkoff; J R Krebs
Journal:  Pa Med       Date:  1989-01

6.  Establishment of the Colorado Physician Health Program with a legislative initiative.

Authors:  E Casper; S L Dilts; J J Soter; R B Lepoff; J H Shore
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

7.  Addiction in anesthesiologists: drug access and patterns of substance abuse.

Authors:  K V Gallegos; C H Browne; F W Veit; G D Talbott
Journal:  QRB Qual Rev Bull       Date:  1988-04

Review 8.  Critical issues in urinalysis of abused substances: report of the Substance-Abuse Testing Committee.

Authors: 
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

Review 9.  Legal issues related to drug testing in the clinical laboratory.

Authors:  R T Chamberlain
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

10.  Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of R(-)-methamphetamine following use of nasal inhalers.

Authors:  R L Fitzgerald; J M Ramos; S C Bogema; A Poklis
Journal:  J Anal Toxicol       Date:  1988 Sep-Oct       Impact factor: 3.367

View more
  26 in total

1.  [Personal crises and catastrophes].

Authors:  V Wenzel
Journal:  Anaesthesist       Date:  2010-05       Impact factor: 1.041

2.  Anesthesiologists recovering from chemical dependency: can they safely return to the operating room?

Authors:  Michael R Oreskovich; Ryan M Caldeiro
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

3.  Environmental cues and relapse: an old idea that is new for reentry of recovering anesthesia care professionals.

Authors:  Heather Wilson
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

4.  Determinants of fentanyl and other potent µ opioid agonist misuse in opioid-dependent individuals.

Authors:  Theodore J Cicero; Matthew S Ellis; Alethea Paradis; Zachary Ortbal
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-10       Impact factor: 2.890

5.  Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS).

Authors:  Justin L Poklis; Amanda J Mohs; Carl E Wolf; Alphonse Poklis; Michelle R Peace
Journal:  J Anal Toxicol       Date:  2016-07-29       Impact factor: 3.367

6.  [Deaths from propofol abuse : Survey of institutes of forensic medicine in Germany, Austria and Switzerland].

Authors:  C Maier; J Iwunna; M Tsokos; F Mußhoff
Journal:  Anaesthesist       Date:  2017-01-13       Impact factor: 1.041

7.  Controlled substance diversion in health systems: A failure modes and effects analysis for prevention.

Authors:  Karen Nolan; Andrew R Zullo; Elliott Bosco; Christine Marchese; Christine Berard-Collins
Journal:  Am J Health Syst Pharm       Date:  2019-07-18       Impact factor: 2.637

8.  [Addictive disorders in physicians].

Authors:  Ahmad Bransi; Lotta Winter; Alexander Glahn; Kai G Kahl
Journal:  Nervenarzt       Date:  2020-01       Impact factor: 1.214

9.  The prevalence of employed nurses identified or enrolled in substance use monitoring programs.

Authors:  Todd B Monroe; Heidi Kenaga; Mary S Dietrich; Michael A Carter; Ronald L Cowan
Journal:  Nurs Res       Date:  2013 Jan-Feb       Impact factor: 2.381

10.  Risk and Outcomes of Substance Use Disorder among Anesthesiology Residents: A Matched Cohort Analysis.

Authors:  David O Warner; Keith Berge; Huaping Sun; Ann Harman; Andrew Hanson; Darrell R Schroeder
Journal:  Anesthesiology       Date:  2015-10       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.